Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Samalizumab Biosimilar – Anti-CD200 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-G4-kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Samalizumab Biosimilar - Anti-CD200 mAb - Research Grade |
|---|---|
| Source | CAS 1073059-33-2 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Samalizumab,ALXN6000,Anti-CD200,hB7V3V2 G2G4,CD200,anti-CD200 |
| Reference | PX-TA1250 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-G4-kappa |
| Clonality | Monoclonal Antibody |
Description of Samalizumab Biosimilar - Anti-CD200 mAb - Research Grade
General information on Anti-CD200[Homo sapiens] (Samalizumab) Monoclonal Antibody
Samalizumab has beeninvestigated for the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.
Related products
Antigen
CD200 recombinant protein
PX-P5207 500$
Isotype Control
Human IgG2 Isotype Control antibody (HyHEL-10)
PTX17900 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.